Status:
UNKNOWN
Predicting the Risk of Post-operative Delirium: Use of Neuropsychology, Serum and CSF Biomarkers and Genetics to Predict Risk of Post-operative Delirium
Lead Sponsor:
Belfast Health and Social Care Trust
Conditions:
Delirium
Eligibility:
All Genders
65+ years
Brief Summary
The purpose of the study is to determine if pre-operative neuropsychological characteristics, apolipoprotein E4 status and/or cerebrospinal fluid (CSF) and serum biomarkers can predict those most at r...
Eligibility Criteria
Inclusion
- living at home
- undergoing primary, elective hip or knee arthroplasty
- spinal anaesthetic with intrathecal diamorphine anticipated
Exclusion
- neurological, hearing or visual disability affecting ability to participate in study
- known neurodegenerative condition eg dementia, Parkinson's disease, multiple sclerosis
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
316 Patients enrolled
Trial Details
Trial ID
NCT02299037
Start Date
March 1 2012
End Date
February 1 2025
Last Update
December 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Public Health, Queen's University Belfast
Belfast, United Kingdom, BT12 6BA